Anti-HBc levels are associated with HBV infection stage, with participants in the immune clearance phase and having HBeAg-negative hepatitis having higher median anti-HBc levels than those in the immune tolerance and low-replicative phases [13]. The gene discussed is KRT88P; the disease is Hepatitis.